Momanose (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momanose, is a glucocorticoid presented as a nasal spray for nasal use. It reduces inflammation in the nasal passages and is indicated for allergic rhinitis and nasal polyps in adults and children.

GNH USA supplies Momanose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global logistics for bulk and parcel orders. Customers benefit from comprehensive regulatory support and on‑time delivery across multiple continents.

Momanose (mometasone furoate) acts on nasal inflammatory pathways to relieve symptoms of upper‑airway allergic conditions.

Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea, improving daily comfort. Nasal polyps: decreases polyp size and edema, helping restore normal nasal airflow and reduce obstruction.

Adverse reactions may occur with nasal administration of mometasone furoate. Most are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleeds) - Throat irritation or dryness - Altered taste or bitter after‑taste - Cough

Serious or Rare Side Effects: - Nasal septal perforation - Severe allergic reaction (anaphylaxis) - Vision changes or cataract formation - Adrenal suppression with prolonged high‑dose use - Opportunistic infections in the nasal cavity

Before using Momanose, consider the following safety measures. - Assess severity: ensure the condition warrants a topical corticosteroid. - Avoid prolonged use: limit duration to the shortest effective period. - Monitor for infection: discontinue if secondary fungal or bacterial infection develops. - Use with caution in patients with glaucoma or cataracts. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Momanose may interact with other medicines that affect corticosteroid activity or metabolism.

Major Interactions (Avoid): - Systemic corticosteroids: additive immunosuppression and adrenal effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase local exposure.

Moderate Interactions (Monitor Closely): - Antihistamines and decongestants: may alter symptom perception. - Other intranasal medications (e.g., saline sprays, antihistamine sprays): stagger administration to reduce irritation. - Immunosuppressants: watch for increased infection risk.